Ginkgo Bioworks Q1 2024 Update Business Review

Ginkgo Bioworks' Q1 2024 business review covering operational updates, financial outlook, and strategic initiatives including site consolidation and workforce adjustments. The presentation details progress toward adjusted EBITDA breakeven, Biofab1 opening timeline, and expansion of biodefense capabilities through the bioradar network and AI tools development.